Semanteon Capital Management LP Purchases New Position in Phibro Animal Health Co. (NASDAQ:PAHC)

Semanteon Capital Management LP purchased a new stake in shares of Phibro Animal Health Co. (NASDAQ:PAHC) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 19,860 shares of the company’s stock, valued at approximately $417,000.

A number of other hedge funds also recently bought and sold shares of the business. Rhumbline Advisers increased its holdings in Phibro Animal Health by 0.6% during the 4th quarter. Rhumbline Advisers now owns 76,582 shares of the company’s stock valued at $1,608,000 after purchasing an additional 484 shares during the period. Los Angeles Capital Management LLC increased its holdings in Phibro Animal Health by 2.1% during the 4th quarter. Los Angeles Capital Management LLC now owns 24,042 shares of the company’s stock valued at $505,000 after purchasing an additional 503 shares during the period. BNP Paribas Financial Markets increased its holdings in Phibro Animal Health by 3.1% during the 3rd quarter. BNP Paribas Financial Markets now owns 24,336 shares of the company’s stock valued at $548,000 after purchasing an additional 729 shares during the period. New York State Teachers Retirement System increased its holdings in Phibro Animal Health by 16.7% during the 4th quarter. New York State Teachers Retirement System now owns 5,428 shares of the company’s stock valued at $114,000 after purchasing an additional 775 shares during the period. Finally, SG Americas Securities LLC increased its holdings in Phibro Animal Health by 7.4% during the 4th quarter. SG Americas Securities LLC now owns 13,162 shares of the company’s stock valued at $276,000 after purchasing an additional 906 shares during the period. Hedge funds and other institutional investors own 99.34% of the company’s stock.

Phibro Animal Health Stock Performance

PAHC stock opened at $21.90 on Friday. The stock has a market capitalization of $887.02 million, a PE ratio of 45.63, a price-to-earnings-growth ratio of 0.45 and a beta of 0.58. The company has a current ratio of 3.20, a quick ratio of 1.37 and a debt-to-equity ratio of 2.99. The stock’s 50 day simple moving average is $22.68 and its 200 day simple moving average is $22.59. Phibro Animal Health Co. has a 12-month low of $12.07 and a 12-month high of $26.55.

Phibro Animal Health (NASDAQ:PAHC) last announced its earnings results on Wednesday, February 5th. The company reported $0.54 earnings per share for the quarter, beating analysts’ consensus estimates of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. As a group, research analysts forecast that Phibro Animal Health Co. will post 1.95 earnings per share for the current fiscal year.

Phibro Animal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Wednesday, March 5th will be paid a $0.12 dividend. The ex-dividend date is Wednesday, March 5th. This represents a $0.48 annualized dividend and a dividend yield of 2.19%. Phibro Animal Health’s dividend payout ratio (DPR) is 100.00%.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the company. StockNews.com upgraded Phibro Animal Health from a “hold” rating to a “buy” rating in a report on Saturday, March 15th. Barclays upped their target price on Phibro Animal Health from $20.00 to $22.00 and gave the stock an “underweight” rating in a report on Monday, February 10th. Finally, Morgan Stanley boosted their price target on Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a research report on Tuesday, December 17th. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating and one has given a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $21.00.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.